The DOI matches its Crossref record; 118 of the 121 references it cites were found in a registry or an index.
Minireview: Adiposity, Inflammation, and Atherogenesis
Abstract
Adipose tissue is a dynamic endocrine organ that secretes a number of factors that are increasingly recognized to contribute to systemic and vascular inflammation. Several of these factors, collectively referred to as adipokines, have now been shown regulate, directly or indirectly, a number of the processes that contribute to the development of atherosclerosis, including hypertension, endothelial dysfunction, insulin resistance, and vascular remodeling. Several adipokines are preferentially expressed in visceral adipose tissue, and the secretion of proinflammatory adipokines is elevated with increasing adiposity. Not surprisingly, approaches that reduce adipose tissue depots, including surgical fat removal, exercise, and reduced caloric intake, improve proinflammatory adipokine levels and reduce the severity of their resultant pathologies. Systemic adipokine levels can also be favorably altered by treatment with several of the existing drug classes used to treat insulin resistance, hypertension, and hypercholesterolemia. Greater understanding of adipokine regulation, however, should result in the design of improved treatment strategies to control disease states associated with increase adiposity, an important outcome in view of the growing worldwide epidemic of obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, higher aortic pulse-wave velocity, a measure of aortic stiffness, strongly correlates with increases in BMI, waist circumference and waist-hip ratio independent of systolic blood pressure, race, and sex19,20.”
From Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms (2015) · cites this paper as [20]
In the citing paper
“There is evidence that excess visceral fat is an important source of cytokines and other factors that create a milieu of oxidative stress and inflammation that contributes to endothelial dysfunction, vascular stiffening, and eventually atherosclerosis20.”
From Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms (2015) · cites this paper as [20]
In the citing paper
“White adipose tissue (WAT), now considered as a pivotal endocrine organ, contributes to the systemic inflammation by producing biomolecules, including pro-inflammatory mediators, whose estimated number grows constantly and whose synthesis is altered along with the expansion of the adipose tissue [6,7].”
From Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity (2008) · cites this paper as [7]
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Flagged first, then by citations
3 of the 121 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 760
Diego, V. P., Rainwater, D. L., Wang, X.-L., Cole, S. A., Curran, J. E., Johnson, M. P., Jowett, J. B. M., Dyer, T. D., Williams, J. T., Moses, E. K., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/510497 · Cited by 23
Features Analysis of Lower Extremity Arterial Lesions in 162 Diabetes Patients
Guo, X., Ya-xue, S. H. I., Huang, X., Ye, M., Xue, G., & Zhang, J. (2013) · Journal of Diabetes Research · doi:10.1155/2013/781360 · Cited by 23
“Recent studies have found that type 2 diabetes and atherosclerosis may be parallelly developed from the same pathological changes [8], the common basis of which is the subacute, non-infectious inflammatory response caused by excessive oxidative stress.”
Biological Characteristics and Agonists of GPR120 (FFAR4) Receptor: The Present Status of Research
Li, A., Li, Y., & Du, L. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.75 · Cited by 23
Moran, L., Fraser, L. M., Sundernathan, T., Deussen, A. R., Louise, J., Yelland, L. N., Grivell, R. M., Macpherson, A., Gillman, M. W., Robinson, J. S., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0790-z · Cited by 22
Kreier, F., Kalsbeek, A., Ruiter, M., Yılmaz, A., Romijn, J. A., Sauerwein, H. P., Fliers, E., & Buijs, R. M. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.092 · Cited by 23
“(Lyon et al., 2003; Matarese et al., 2002).”
The realities of dyslipidaemia: what do the studies tell us?
Kastelein, J. J. P. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui040 · Cited by 23
Munkholm, K., Jacoby, A. S., Lenskjold, T., Bruunsgaard, H., Vinberg, M., & Kessing, L. V. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.01.022 · Cited by 25
Guías para el tratamiento de las dislipemias en el adulto: Adult Treatment Panel III (ATP-III)
Rubio, M. Á., Moreno, C., & Cabrerizo, L. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74614-8 · Cited by 30
Dodd, J. M. (2014) · Annals of Nutrition and Metabolism · doi:10.1159/000365018 · Cited by 23
Jiang, B., Qiao, J., Yang, Y., & Lu, Y. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22173 · Cited by 22
“Elevated FFA and chronic, low-grade inflammation are two mediators in the process [Fernandez-Real and Ricart, 2003; Lyon et al., 2003; Dandona et al., 2005].”
BackgroundRallidis, L. S., Barοutsi, K., Zolindaki, M., Karagianni, M., Varounis, C., Dagres, N., Lekakis, J. P., & ANASTASIOU‐NANA, M. I. (2014) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2013.12.017 · Cited by 22
“WC is considered a surrogate measure of VAT, and there are data suggesting that WC is associatedwith the risk of developingCVD (Balkau et al. 2007; Siren et al. 2012).”
BackgroundMatossian, D. (2018) · Pediatric Annals · doi:10.3928/19382359-20181119-01 · Cited by 22
Litvinova, L. S., Atochin, D. N., Василенко, М., Fattakhov, N. S., Затолокин, П. А., Вайсбейн, И. З., & Кириенкова, Е. В. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-137 · Cited by 21
“In obesity, the increased production of inflammation mediators in the adipose tissue, liver, pancreas and skeletal muscles causes subclinical metabolic inflammation [5,8,9].”
BackgroundLow-Grade Inflammation and Role of Anti-Inflammatory Diet in Childhood Obesity
Polak-Szczybyło, E. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20031682 · Cited by 21
A quantitative model of thermal injury-induced acute inflammation
Yang, Q., Francois Berthiaume, B., & Androulakis, I. P. (2010) · Mathematical Biosciences · doi:10.1016/j.mbs.2010.08.003 · Cited by 21
Agredo-Zúñiga, R. A., Plata, C. A., & Suárez‐Ortegón, M. F. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002275 · Cited by 21
“Obesity is considered as a state of sub-clinical inflammation characterised by the secretion of cytokines that promote atherosclerotic plaque formation and consequent endothelial dysfunction((4)).”
BackgroundMediouni, M., Kaczor‐Urbanowicz, K. E., & Madiouni, R. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100240 · Cited by 21
Depot-Specific Changes in Fat Metabolism with Aging in a Type 2 Diabetic Animal Model
Park, S. E., Park, C., Choi, J. M., Chang, E., Rhee, E., Lee, W., Oh, K. W., Park, S. W., Kang, E. S., Lee, H. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148141 · Cited by 20
Thandassery, R. B., Appasani, S., Yadav, T. D., Dutta, U., Abujam, I., Singh, K., & Kochhar, R. K. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-3000-7 · Cited by 20
“Obese humans have increased levels of several proinflammatory cytokines including adipocytokines [7].”
BackgroundHeinl, R. E., Dhindsa, D. S., Mahlof, E. N., Schultz, W. M., Ricketts, J. C., Varghese, T., Esmaeeli, A., Allard‐Ratick, M., Millard, A. J., Kelli, H. M., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.507 · Cited by 20
Seo, J.-S., Jin, H., Jang, J., Yang, T., Kim, D.-K., & Kim, D. (2017) · Journal of Cardiovascular Ultrasound · doi:10.4250/jcu.2017.25.1.5 · Cited by 20
Saeed, S., Waje‐Andreassen, U., & Nilsson, P. M. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1807327 · Cited by 20
Kumagai, S., Kishimoto, H., Suwa, M., Zou, B., & Harukasasaki (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.85 · Cited by 22
“Leptin is known as one of the adipocyte-kines 12,13 CVD. 13–15 It is also thought to modulate atherosclerosis .”
Obesidade, inflamação e exercício: foco sobre o TNF-alfa e IL-10
Speretta, G. F. F., Leite, R. D., & Duarte, A. C. D. O. (2014) · Revista Hospital Universitário Pedro Ernesto · doi:10.12957/rhupe.2014.9807 · Cited by 20
Mobilization of pro-inflammatory lipids in obese Plscr3-deficient mice
Mutch, D. M., O’Maille, G., Wikoff, W. R., Wiedmer, T., Sims, P. J., & Siuzdak, G. E. (2007) · Genome biology · doi:10.1186/gb-2007-8-3-r38 · Cited by 20
“Furthermore, several factors have been shown to regulate atherogenic processes, such as hypertension and vascular remodeling [19,20].”
Li, L., & Renier, G. (2007) · Obesity · doi:10.1038/oby.2007.311 · Cited by 19
HsCRP levels: Measurement of airway inflammation in asthmatic children
Soferman, R., Glatstein, M. M., Sivan, Y., & Weisman, Y. (2008) · Pediatrics International · doi:10.1111/j.1442-200x.2007.02517.x · Cited by 19
The Role of Visceral Adipose Tissue in the Pathogenesis of Non-alcoholic Fatty Liver Disease
Verrijken, A., Francque, S., & Gaal, L. V. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2011.07.02.96 · Cited by 18
Brahmbhatt, T. S., Hernon, M., Siegert, C., Plauche, L. M., Young, L. S., & Burke, P. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0264-9 · Cited by 19
Svensson, J., Herlitz, H., Lundberg, P., & Johannsson, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1239 · Cited by 19
“glucose homeostasis, have been pointed out (11).”
Boehm, B. O., & Claudi‐boehm, S. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510500236044 · Cited by 21
“fat cells) includes proteins involved in lipid metabolism, insulin sensitivity, the alternative complement system, vascular haemostasis, blood pressure regulation and angiogenesis, as well as the regulation of energy balance (46, 47).”
BackgroundZhang, X., Liu, S., & Zhou, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11853 · Cited by 18
Effects of risk factors for ovarian cancer in women with and without endometriosis
Phung, M. T., Muthukumar, A., Trabert, B. L., Webb, P. M., Jordan, S. J., Terry, K. L., Cramer, D. W., Titus, L. J., Risch, H. A., Doherty, J. A., et al. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.07.019 · Cited by 19
Lin, W., & Lin, M.-E. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03840-6 · Cited by 18
Effects of C-reactive protein on adipokines genes expression in 3T3-L1 adipocytes
Yuan, G., Jia, J., Di, L., Zhou, L., Dong, S., Ye, J., Wang, D., Yang, L., Wang, J., Li, L., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.133 · Cited by 18
Basati, G., Razavi, À. E., Abdi, S., & Sarrafzadegan, N. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.13.131 · Cited by 18
[Role of inflammation in atherogenesis].
Rodríguez, G., Mago, N., & Rosa, F. (2009) · PubMed · Cited by 26
Ke, L., Chan, H., Chan, H., Kalu, F. C. U., Lee, H., Lin, I., Jhuo, S., Lai, W., Tsao, C., Sawamura, T., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01657 · Cited by 17
Resistin and Visfatin Expression in HCT-116 Colorectal Cancer Cell Line.
Ghaemmaghami, S., Mohaddes, S. M., Hedayati, M., Mohammadi, M. G., & Dehbashi, G. (2013) · Europe PMC (PubMed Central) · Cited by 17
Pathophysiology of Obesity—Induced Hypertension and Target Organ Damage
Hall, J. E., da Silva, A. A., Brandon, E. L., Stec, D. E., Ying, Z., & Jones, D. W. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50041-6 · Cited by 18
Dąbrowska, E., Harazny, J. M., Miszkowska-Nagórna, E., Stefański, A., Graff, B., Kunicka, K. B., Świerblewska, E., Rojek, A., Szyndler, A., Gąsecki, D., et al. (2020) · Microvascular Research · doi:10.1016/j.mvr.2020.103974 · Cited by 17
Won, J. C., Park, C., Oh, S. W., & Park, S. W. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00213.x · Cited by 17
Subtherapeutic Dose of Pioglitazone Reduces Expression of Inflammatory Adipokines in db/db Mice
Mohapatra, J., Sharma, M., Singh, S. K., Chatterjee, A., Swain, P. K., Balaraman, R., Patel, P., & Jain, M. R. (2009) · Pharmacology · doi:10.1159/000235996 · Cited by 17
Mizia‐Stec, K., Haberka, M., Mizia, M., Chmiel, A., Gieszczyk-Strózik, K., Lasota, B., Janowska, J., Zahorska‐Markiewicz, B., & Gąsior, Z. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.25553 · Cited by 17
“On the other hand, a growing body of evidence suggests that adipose tissue is considered to be an important organ that secretes adipokines and is involved in the development of endothelial dysfunction and cardiovascular and metabolic diseases [10, 11].”
BackgroundAdiponectin Gene Polymorphism and its Association with Type 2 Diabetes Mellitus
Biswas, D., Venkatesan, V., Choudhury, J., & Jothimalar, R. (2011) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-011-0123-5 · Cited by 17
“Two mutants are incapable of forming the high molecular weight species while three are incapable of forming a stable trimer and show impaired secretion as well [13].”
BackgroundCaïjo, F., Mosset, P., Gree, R. L., Audinot, V., Boutin, J. A., Renard, P., Caignard, D., & Dacquet, C. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.049 · Cited by 17
Fujimori, K., Uno, S., Kuroda, K., Matsumoto, C., & Maehara, T. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119203 · Cited by 16
Association between retinal vessels caliber and systemic health: A comprehensive review
Lee, S. J. V., Goh, Y. Q., Rojas-Carabali, W. A., Cifuentes‐González, C., Cheung, C. Y.-L., Arora, A., de‐la‐Torre, A., Gupta, V., & Agrawal, R. V. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.11.009 · Cited by 18
Cardiovascular Risk Evaluated by C-Reactive Protein Levels in Diabetic and Obese Mexican Subjects
Flores‐Alfaro, E., Parra‐Rojas, I., Salgado-Bernabé, A. B., Chávez‐Maldonado, J. P., & Salazar-Martı́nez, E. (2008) · Circulation Journal · doi:10.1253/circj.72.1170 · Cited by 16
“Methods and Results The study enrolled 385 men and women who were classified into 4 groups: (1) diabetes (n=97), (2) obesity (n=108), (3) diabetes/obesity (n=78), and (4) healthy (n=102).”
BackgroundDias, T. R., Bernardino, R. L., Meneses, M. J., Sousa, M., Sá, R., Alves, M. G., Silva, B. M., & Oliveira, P. F. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666160229113629 · Cited by 16
Nakai, K., Watari, J., Tozawa, K., Tamura, A., Hara, K., Yamasaki, T., Kondo, T., Kono, T., Tomita, T., Ohda, Y., et al. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-11 · Cited by 16
“(50) 51–53) It has also been reported that plasma adiponectin levels, particularly HMW adiponectin analyzed in this study, is a convenient and sensitive biomarker for the prediction of insulin resistance (HOMA-IR).”
Increased serum resistin levels in patients with coronary slow-flow phenomenon
Çanğa, A., Çetın, M., Kocaman, S. A., Durakoğlugil, M. E., Kırbaş, A., Erdoğan, T., Temız, A., Yılmaz, A., & Çiçek, Y. (2013) · Herz · doi:10.1007/s00059-013-3758-6 · Cited by 16
Immunological Aspects of Atherosclerosis
Králová, A., Lesná, I. K., & Poledne, R. (2014) · Physiological Research · doi:10.33549/physiolres.932858 · Cited by 16
“There is considerable evidence that visceral fat in obesity plays 2014 Immunity and Atherosclerosis S337 a crucial role in the inflammatory process as a chronic inflammatory disease with dysregulation of pro- and antiinflammatory cytokine production (for summary see Lyon et al. 2003).”
BackgroundRelationship between serum visfatin levels and coronary slow-flow phenomenon
Çakmak, H. A., Aslan, S., Yalçın, A. A., Aktürk, İ. F., Yalçin, B., Uzun, F., Öztürk, D., Ertürk, M., & Gül, M. (2015) · Herz · doi:10.1007/s00059-015-4313-4 · Cited by 16
Characterization of proteins regulated by interleukin-4 in 3T3-L1 adipocytes
Shiau, M., Lu, H.-F., Chang, Y.-H., Chiu, Y.-C., & Shih, Y. (2015) · SpringerPlus · doi:10.1186/s40064-015-0980-0 · Cited by 15
“Dysregulated production of these adipokines is implicated in obesity and related metabolic consequences (Chaldakov et al. 2003; Lyon et al. 2003).”
BackgroundRelation of chemokines to BMI and insulin resistance at ages 18–21
Ognjanovic, S., Jacobs, D. R., Steinberger, J., Moran, A. E., & Sinaiko, A. R. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.61 · Cited by 15
Relationship of blood pressure and obesity with inflammatory cytokines among African Americans
DeLoach, S. S., Huan, Y., Keith, S. W., Cantarin, M. P. M., & Falkner, B. E. (2011) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944711408757 · Cited by 14
Caries Experience and Salivary Parameters among Overweight Children and Adolescents
Guaré, R. D. O., Ciamponi, A. L., Santos, M. J., Gorjão, R., & Diniz, M. B. (2013) · Dentistry Journal · doi:10.3390/dj1040031 · Cited by 15
“IL-6 is produced by adipocytes, monocytes, macrophages, lymphocytes and fibroblasts and stimulates T cell proliferation, activation, apoptosis and cytotoxicity.”
InfluentialFirst-Trimester Adiponectin and Subsequent Development of Preeclampsia or Fetal Growth Restriction
Valdés, E., Lattes, K., Hernán Muñoz, S., Barja, P., & Papapietro, K. (2011) · Gynecologic and Obstetric Investigation · doi:10.1159/000328418 · Cited by 15
Han, L., Tang, M., Ti, Y., Wang, Z., Wang, J., Ding, W.-Y., Wang, H., Zhang, Y., Zhang, W., & Zhong, M. (2013) · PLoS ONE · doi:10.1371/annotation/39606c88-c2a1-45e7-8b2d-9b8f7df6f05f · Cited by 15
Understanding the prevalence, progression, and management of metabolic syndrome in Saudi Arabia
Alshehri, F. F. (2023) · Saudi Medical Journal · doi:10.15537/smj.2023.44.10.20230450 · Cited by 15
“60-62 Inflammatory adipokines promote the generation of superoxide (a type of ROS), inflammatory mediators, and adhesion components through NF-k B stimulation, thereby exacerbating pathological mechanisms such as LDL oxidation, dyslipidemia, insulin resistance, glucose intolerance, endothelial…”
BackgroundWang, C.-P., Chung, F., Shin, S., & Lee, Y. (2007) · The Review of Diabetic Studies · doi:10.1900/rds.2007.4.77 · Cited by 15
“Adipocytokine release may elucidate the relationship between obesity and cardiovascular phenotypes, including hypertension and atherosclerosis, mainly through their ability to affect and modify endothelial and vascular function as well as by their modulating effects on immune functions, which have been elucidated in s…”
BackgroundYang, T. T. C., Ung, P. M. U., Rincón, M., & Chow, C.-W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511214200 · Cited by 14
Obesidad abdominal: un estandarte del riesgo cardiometabólico
Salvador, J., Silva, C., Pujante, P., & Frühbeck, G. (2008) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(08)75079-4 · Cited by 14
Adiponectin Ameliorates Endotoxin-Induced Acute Cardiac Injury
Watanabe, Y., Shibata, R., Ouchi, N., Kambara, T., Ohashi, K., Li, J., Inoue, Y., Murohara, T., & Komori, K. (2014) · BioMed Research International · doi:10.1155/2014/382035 · Cited by 14
Madarshahian, F., Hassanabadi, M., & Nikoo, M. K. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-31 · Cited by 14
“Some studies suggested adipose tissue secretes factors such as adipokines that contribute to systemic and vascular inflammation, development of atherosclerosis and diabetes complications [8].”
BackgroundVasoactive Factors and Inflammatory Mediators Produced in Adipose Tissue
Frühbeck, G. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-370-7_5 · Cited by 14
Mechanisms of the metabolic syndrome
Mehta, N. N., & Reilly, M. P. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.09.010 · Cited by 14
Cai, M., Yin, W., Li, Q., Liao, D., Tsutsumi, K., Hou, H., Liu, Y., Zhang, C., Li, J., Wang, Z., et al. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.04.032 · Cited by 14
Liu, Z. H., Zhang, G. X., Zhang, H., Li, J., Deng, Y., Chan, F. S., & Fan, J. K. M. (2021) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12979 · Cited by 13
Farhadnejad, H., Teymoori, F., Jahromi, M. K., Mokhtari, E., Asghari, G., Mirmiran, P., & Azizi, F. (2023) · Nutrition Journal · doi:10.1186/s12937-023-00835-y · Cited by 13
“It has been revealed that adiposity is linked to the higher levels of various inflammatory indicators such as IL-6, TNF-α, and adipokines [37, 38] that, in this way, indirectly lead to disruption of kidney function [39].”
BackgroundInflammatory Markers in Pediatric Obesity
Stolzman, S. C., & Bement, M. H. (2012) · ICAN Infant Child & Adolescent Nutrition · doi:10.1177/1941406412459344 · Cited by 13
Metabolic Syndrome and Myocardial Infarction in Women
Μacut, D., Ognjanovic, S. I., Ašanin, M., Krljanać, G., & Milenković, T. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210610114029 · Cited by 15
Kanaya, A. M., Dobrosielski, D. A., Ganz, P., Creasman, J. M., Gupta, R., Nelacanti, V., Vogel‐Claussen, J., & Herrington, D. M. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.004283 · Cited by 13
“Current smoker 427 (12) 127 (11) 33 (5) 146 (19) 116 (13) 5 (4)”
Insulin Action and Distribution of Tissue Blood Flow
Bergman, R. N. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031431 · Cited by 15
“Resistance is a risk factor not only for diabetes but also for dyslipidemia (1, 2), hypertension (3), cardiovascular disease (2, 4), colon cancer (5, 6), and possibly breast cancer (7).”
BackgroundLi, M., Lin, J., Liang, S., Huang, S., Wen, Z. X., & Mo, Z. (2022) · Obesity Facts · doi:10.1159/000524653 · Cited by 14
Okamura, H., Yang, D., Yoshida, K., Teramachi, J., & Haneji, T. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.06.008 · Cited by 12
Differential effects of energy balance on experimentally-induced colitis
McCaskey, S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i7.627 · Cited by 12
Huang, M., Wang, T., Lee, K., Wu, Y., Tu, H., Liu, C., Chiang, H., & Ko, Y. (2010) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(10)70033-4 · Cited by 12
“In addition, there is a greater likelihood that insulin resistance and endothelial dysfunction will progress to type 2 diabetes and atherosclerosis in people with central obesity [11].”
BackgroundXin, X.-M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15727 · Cited by 12
Wei, J., Ma, C., & Wang, X. (2006) · Biomedical Research · doi:10.2220/biomedres.27.149 · Cited by 11
Relationship of glucose concentrations with PAI‐1 and t‐PA in subjects with normal glucose tolerance
Heldgaard, P. E., Sidelmann, J. J., Hindsberger, C., Olivarius, N. D. F., Henriksen, J. E., & Gram, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01924.x · Cited by 11
“Obesity, in particular central obesity, is a pro-inflammatory condition associated with hypofibrinolysis, most likely as a result of increased production of PAI-1 and other cytokines in the adipose tissue [ 38 ].”
BackgroundYbarra, J., Pou, J. M., Planas, F., Ballesta‐López, C., Echevarne, F., Romeo, J. H., & Navarro‐López, F. (2007) · Endocrine Practice · doi:10.4158/ep.13.6.590 · Cited by 11
Inflammation dans le tissu adipeux péri-artériel et athérome
Hamlat, N., Neggazi, S., Ayari, H., Feugier, P., Bricca, G., Bouguerra, S. A., & Beylot, M. (2017) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2017.01.001 · Cited by 11
Reduced plasma adiponectin in NASH
Tietge, U. J. F., Schmidt, H., Schütz, T., Dippe, P., Lochs, H. H., & Pirlich, M. (2005) · Hepatology · doi:10.1002/hep.20546 · Cited by 11
Shatnawi, N. J., Al-Zoubi, N. A., Hawamdeh, H. M., Khader, Y. S., Heis, M., Al-Omari, M., & Bataineh, B. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211000504 · Cited by 11
Kochumon, S., Arefanian, H., Sindhu, S. T. A. K., Thomas, R., JACOB, T. K., Al-Sayyar, A., Shenouda, S., Al‐Rashed, F., Koistinen, H. A., Al‐Mulla, F., et al. (2022) · Cells · doi:10.3390/cells11244007 · Cited by 10
Gonçalves, W. L. S., Cirqueira, J. P., Soares, L. S., Bissoli, N. S., & Moysés, M. R. (2005) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962005001000015 · Cited by 10
“Adicionalmente, o TNF-α atua sinergicamente com outras citocinas (interleucina 6 – IL-6, proteína C Reativa – PCR e Resistina), também secretadas pelos adipócitos durante a ativação de processos inflamatórios, ampliando o risco de injúrias endoteliais, diminuindo os fatores de relaxamento e elevando os fatores de cont…”
BackgroundMelles, E., J�rnvall, H., Tryggvason, S., Gemzell‐Danielsson, K., Ekberg, K., Tryggvason, K., Wahren, J., & Bergman, T. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4313-7 · Cited by 10
CYP450, COX-2 and Obesity Related Renal Damage
Imig, J. D., Zhao, X., Dey, A., & Shaw, M. (2005) · Toxicology Mechanisms and Methods · doi:10.1080/15376520590918856 · Cited by 10
“In addition, PAI-1 is a key factor in atherosclerosis that is associated with obesity and metabolic syndrome (Lyon, Law, and Hsueh 2003; El-Atat et al. 2004; Davy and Hall 2004).”
BackgroundSíndrome metabólica e artrite idiopática juvenil
Zanette, C. D. A., Machado, S. H., Brenol, J. C. T., & Xavier, R. M. (2010) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042010000200008 · Cited by 11
Zhou, Y., Liu, B., Liu, K., Tang, N., Huang, J., An, Y., & Li, L. (2008) · Inflammation · doi:10.1007/s10753-008-9086-y · Cited by 10
“Inflammation provided a train of thoughts to understand how diet, physiological stress and obesity promoted insulin resistance [24, 25].”
BackgroundNegrão, R., & Faria, A. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9701-0_8 · Cited by 10
“Obesity is now recognized as a state of chronic, low-grade inflammation (Lyon et al. 2003).”
BackgroundOmental infarction in children: imaging features with pathological correlation.
Lee, W., Ong, C. L., Chong, C. C. L., & Hwang, W. S. (2005) · PubMed · Cited by 10
Role of modulator recognition factor 2 in adipogenesis and leptin expression in 3T3-L1 cells
Dong, J., Ishimori, N., Paigen, B. J., Tsutsui, H., & Fujii, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.002 · Cited by 10
Li, H., Lee, W., Chen, M.-J., & Chuang, L. (2005) · Obesity Research · doi:10.1038/oby.2005.98 · Cited by 10
Glucocorticoid receptor-NECAB1 axis can negatively regulate insulin secretion in pancreatic β-cells
Udagawa, H., Funahashi, N., Nishimura, W., Uebanso, T., Kawaguchi, M., ASAHI, R., Nakajima, S., Nammo, T., Hiramoto, M., & Yasuda, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-44324-y · Cited by 9
Duque-Guimaraes, D. E., de Castro, J., Martı́nez-Botas, J., Sardinha, F. L. C., Ramos, P., & Herrera, E. (2009) · Cited by 9
Gong, W., Hu, Y., Niu, Y. Y., Wang, D., Wang, Y., Li, Y., Holden, B. A., & He, M. (2016) · Obesity · doi:10.1002/oby.21398 · Cited by 9
“Concomitant production of inflammatory and vasoconstrictor factors (TNFa, IL-6, angiotensin-II, endothelin-1, and other metabolites of arachidonic acid) would lead to retinal arteriolar narrowing (26,27).”
BackgroundÖnal, A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73958 · Cited by 9
Metadata
- Authors
- Lyon, C. J., Law, R. E., & Hsueh, W. A.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Hsueh, Willa A.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2003-06-01
- Volume
- 144
- Issue
- 6
- Pages
- 2195-2200
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1981444005
- Cited by
- 761
- References
- 121
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 7 · 2023: 11 · 2022: 15 · 2021: 12 · 2020: 16 · 2019: 42 · 2018: 23 · 2017: 31 · 2016: 20 · 2015: 39 · 2014: 31 · 2013: 31 · 2012: 37
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (1P01 HIG0030-01A1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- adiposity, adipokines, atherosclerosis, vascular inflammation, visceral adipose tissue, obesity, insulin resistance, hypertension, endothelial dysfunction, vascular remodeling, bariatric surgery, physical activity, caloric restriction, anti-inflammatory agents, hypercholesterolemia
- MeSH terms
- Adipose Tissue, Animals, Arteriosclerosis, Humans, Obesity, Vasculitis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review